Pharmacological blockade of cannabinoid type II receptors and mesenchymal stem cell transplantation in a model of peripheral neuropathic pain

Pharmacological blockade of cannabinoid type II receptors and mesenchymal stem cell transplantation in a model of peripheral neuropathic pain

Objective. To evaluate the anti-nociceptive and reparative effects of adipose-derived mesenchymal stem cells (ADMSCs) under the pharmacological blockade of cannabinoid CB2 receptors in a model of peripheral neuropathic pain.Material and methods. In 40 male Wistar rats, modeling of peripheral neuropa...

Full description

Bibliographic Details
Main Authors:	A.-M. V. Yerofeyeva, S. V. Pinchuk, S. N. Rjabceva, A. Yu. Molchanova
Format:	Article
Language:	Russian
Published:	Scientific Сentre for Family Health and Human Reproduction Problems 2024-01-01
Series:	Acta Biomedica Scientifica
Subjects:	mesenchymal stem cells neuropathic pain sciatic nerve cannabinoid receptors pharmacological blockade of cb2 receptors
Online Access:	https://www.actabiomedica.ru/jour/article/view/4500

Similar Items

The role of cannabinoid CB1 receptors in the antinociceptive and reparative actions of mesenchymal stem cells in rats with peripheral neuropathic pain
by: Anna‐Maria V. Yerofeyeva, et al.
Published: (2023-09-01)

Molecular Pharmacology of Synthetic Cannabinoids: Delineating CB1 Receptor-Mediated Cell Signaling
by: Kenneth B. Walsh, et al.
Published: (2020-08-01)

Cannabinoids and Their Receptors in Skin Diseases
by: Eun Hee Yoo, et al.
Published: (2023-11-01)

Cannabinoid receptor agonist attenuates angiotensin II–induced enlargement and mitochondrial dysfunction in rat atrial cardiomyocytes
by: Danielle I. Altieri, et al.
Published: (2023-04-01)

<i>Cannabis</i>: From a Plant That Modulates Feeding Behaviors toward Developing Selective Inhibitors of the Peripheral Endocannabinoid System for the Treatment of Obesity and Metabolic Syndrome
by: Shira Hirsch, et al.
Published: (2019-05-01)

Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB2 receptor
by: Monica Patel, et al.
Published: (2023-12-01)

Role of Cannabinoid CB2 Receptor in Alcohol Use Disorders: From Animal to Human Studies
by: María Salud García-Gutiérrez, et al.
Published: (2022-05-01)

Saturated Cannabinoids: Update on Synthesis Strategies and Biological Studies of These Emerging Cannabinoid Analogs
by: Maite L. Docampo-Palacios, et al.
Published: (2023-09-01)

Involvement of CB1 and CB2 receptors in neuroprotective effects of cannabinoids in experimental TDP-43 related frontotemporal dementia using male mice
by: Claudia Gonzalo-Consuegra, et al.
Published: (2024-05-01)

Cannabinoid Receptor Modulation of Neurogenesis: ST14A Striatal Neural Progenitor Cells as a Simplified In Vitro Model
by: Erika Cottone, et al.
Published: (2021-03-01)

Voltage dependence of the cannabinoid CB1 receptor
by: Esty Goldberger, et al.
Published: (2022-10-01)

Novel Cannabinoid Receptor 2 (CB2) Low Lipophilicity Agonists Produce Distinct cAMP and Arrestin Signalling Kinetics without Bias
by: Raahul Sharma, et al.
Published: (2023-03-01)

Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review
by: Ahmed Hasbi, et al.
Published: (2023-02-01)

The Selective CB2 Agonist COR167 Reduced Symptoms in a Mice Model of Trauma-Induced Peripheral Neuropathy through HDAC-1 Inhibition
by: Vittoria Borgonetti, et al.
Published: (2023-05-01)

Cannabinoid CB2 receptors and spinal microglia are implicated in tingenone-mediated antinociception in mice
by: Clarice C.V. Moura, et al.
Published: (2021-01-01)

Preventive Intrathecal Injection of Bupivacaine Alleviated Microglia Activation and Neuropathic Pain in a Rat Model of Chronic Constriction Injury
by: Chih-Cheng Wu, et al.
Published: (2022-06-01)

Low Basal CB2R in Dopamine Neurons and Microglia Influences Cannabinoid Tetrad Effects
by: Qing-Rong Liu, et al.
Published: (2020-12-01)

Spinal cannabinoid receptor 2 activation alleviates neuropathic pain by regulating microglia and suppressing P2X7 receptor
by: Yifan Zhou, et al.
Published: (2023-03-01)

Endocannabinoid system and periodontitis: mechanisms and therapeutic implications
by: Lélio Fernando Ferreira SOARES, et al.
Published: (2023-12-01)

The Effect of Anakinra on Acrylamide-induced Peripheral Neuropathy and Neuropathic Pain in Rats
by: Alevtina Ersoy, et al.
Published: (2023-01-01)

Pharmacological insights emerging from the characterization of a large collection of synthetic cannabinoid receptor agonists designer drugs
by: Claudia Gioé-Gallo, et al.
Published: (2023-08-01)

Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products
by: Dongchen An, et al.
Published: (2020-07-01)

Effects of deleting cannabinoid receptor-2 on mechanical and material properties of cortical and trabecular bone
by: Aysha B. Khalid, et al.
Published: (2015-12-01)

Synthesis and pharmacological evaluation of newly detected synthetic cannabinoid receptor agonists AB-4CN-BUTICA, MMB-4CN-BUTINACA, MDMB-4F-BUTICA, MDMB-4F-BUTINACA and their analogs
by: Eric Sparkes, et al.
Published: (2022-09-01)

Tumor necrosis factor α, and agonist and antagonists of cannabinoid receptor type 1 and type 2 alter the immunophenotype of stem cells from human exfoliated deciduous teeth
by: Marizia Trevizani, et al.
Published: (2023-11-01)

Zerumbone Ameliorates Neuropathic Pain Symptoms via Cannabinoid and PPAR Receptors Using In Vivo and In Silico Models
by: Jasmine Siew Min Chia, et al.
Published: (2021-06-01)

Systemic and Peripheral Mechanisms of Cortical Stimulation-Induced Analgesia and Refractoriness in a Rat Model of Neuropathic Pain
by: Danielle V. Assis, et al.
Published: (2023-04-01)

Cannabinoid CB2 Receptors Contribute to Upregulation of β-endorphin in Inflamed Skin Tissues by Electroacupuncture
by: Su Tang-feng, et al.
Published: (2011-12-01)

Synthesis and In Vitro Characterization of Selective Cannabinoid CB2 Receptor Agonists: Biological Evaluation against Neuroblastoma Cancer Cells
by: Francesca Gado, et al.
Published: (2022-05-01)

Structure–Activity Relationship Development Efforts towards Peripherally Selective Analogs of the Cannabinoid Receptor Partial Agonist BAY 59-3074
by: George Amato, et al.
Published: (2022-09-01)

Allosteric Modulation of the CB1 Cannabinoid Receptor by Cannabidiol—A Molecular Modeling Study of the N-Terminal Domain and the Allosteric-Orthosteric Coupling
by: Jakub Jakowiecki, et al.
Published: (2021-04-01)

Investigating the Effects of Exogenous and Endogenous 2-Arachidonoylglycerol on Retinal CB1 Cannabinoid Receptors and Reactive Microglia in Naive and Diseased Retina
by: Sofia Papadogkonaki, et al.
Published: (2023-10-01)

Erratum: Cannabinoid Receptor 2 Signalling Bias Elicited by 2,4,6-Trisubstituted 1,3,5-Triazines
by: Frontiers Production Office
Published: (2019-04-01)

Functional Selectivity of Cannabinoid Type 1 G Protein-Coupled Receptor Agonists in Transactivating Glycosylated Receptors on Cancer Cells to Induce Epithelial–Mesenchymal Transition Metastatic Phenotype
by: David A. Bunsick, et al.
Published: (2024-03-01)

The Peripheral Cannabinoid Receptor Type 1 (CB<sub>1</sub>) as a Molecular Target for Modulating Body Weight in Man
by: Saoirse Elizabeth O’Sullivan, et al.
Published: (2021-10-01)

A Critical Evaluation of Terpenoid Signaling at Cannabinoid CB1 Receptors in a Neuronal Model
by: Michaela Dvorakova, et al.
Published: (2022-09-01)

Mechanisms of Broad-Spectrum Antiemetic Efficacy of Cannabinoids against Chemotherapy-Induced Acute and Delayed Vomiting
by: Nissar A. Darmani
Published: (2010-09-01)

Motifs in Natural Products as Useful Scaffolds to Obtain Novel Benzo[<i>d</i>]imidazole-Based Cannabinoid Type 2 (CB2) Receptor Agonists
by: Analia Young Hwa Cho, et al.
Published: (2023-06-01)

Terminal type-specific cannabinoid CB1 receptor alterations in patients with schizophrenia: A pilot study
by: Shinnyi Chou, et al.
Published: (2023-09-01)

Osteogenic growth peptide is a potent anti-inflammatory and bone preserving hormone via cannabinoid receptor type 2
by: Bitya Raphael-Mizrahi, et al.
Published: (2022-05-01)